Less than half of England has access to tirzepatide (Mounjaro) through their GP, despite the NHS roll-out of the weight-loss jab officially starting over two months ago, an investigation by The BMJ has found.
from Medical Xpress - latest medical and health news stories https://ift.tt/0pZKy7V
